A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: A double-site model for drug absorption Yves PlusquellecG. CampistronG. Houin Introduction 01 June 1987 Pages: 225 - 239
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man Jürgen SchüttlerDonald R. StanskiLewis B. Sheiner Introduction 01 June 1987 Pages: 241 - 253
A minimax approach to the single-point method of drug dosing Mark M. BahnElliot M. Landaw Pharmacometrics 01 June 1987 Pages: 255 - 269
Area method for the estimation of partition coefficients for physiological pharmacokinetic models James M. GalloFred C. LamDonald G. Perrier Pharmacometrics 01 June 1987 Pages: 271 - 280
Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailahility and distribution time concepts applied to the evaluation of distribution kinetics Peter Veng-PedersenWilliam R. Gillespie Pharmacometrics 01 June 1987 Pages: 281 - 304
Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance Peter Veng-PedersenWilliam R. Gillespie Pharmacometrics 01 June 1987 Pages: 305 - 325
The use and abuse of models Aldo RescignoJames S. BeckAjit K. Thakur Perspectives in Pharmacokinetics 01 June 1987 Pages: 327 - 340
Commentary on the article of A. Rescigno and J. S. Beck Ajit K. Thakur Commentary 01 June 1987 Pages: 341 - 344
Erratum to: Effect of caffeine on ceftriaxone disposition and plasma protein binding in the rat Kwang I. KwonDavid W. A. Bourne Erratum 01 June 1987 Pages: 345 - 345
